SEC Tracker
Get the app

Possible new PAVmed shares

PAVMDilution

Known so far: no new shares from the prospectus covers read · shelf room about $3.9M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $3.9M
  • One third of float $3.9M ($11.8M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $3.9M on the S-3 of Apr 21, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $11.8M public float stated as of Jun 30, 2025, $3.9M, nothing sold off it in the last 12 months. Sources: S-3 Apr 21, 2026, effective Apr 29, 2026 · public float, as of Jun 30, 2025.

What could become new PAVmed (PAVM) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (8M shares, +1091% from 671K on Jun 30, 2025, adjusted for the 1-for-30 reverse split by Mar 27, 2026). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

8.0M

Sep 2024 to Aug 2026: from 366K to 8.0M. Adjusted for the 1-for-30 reverse split by Mar 27, 2026: each earlier count is divided by the ratio of every split after it.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.